What will be the impact of the CMD in countries which have already included RCS in their national CMD legislation?

This will be discussed in each Member State during the transposition period of the European Directive. By 2020, Member States must ensure compliance with the minimum standards established by the Directive. It is expected that the Member States who already treat RCS as a carcinogenic agent at the workplace will not make substantial changes to their national law.